00009907632020-01-012020-09-30iso4217:USD00009907632020-09-30xbrli:shares00009907632012-01-012012-03-3100009907632011-01-012011-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 10-K
___________________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For transition period from               to
Commission File Number 001-36773

___________________________________
WORKIVA INC.
(Exact name of registrant as specified in its charter)
___________________________________
Delaware
(State or other jurisdiction of incorporation or organization)
47-2509828
(I.R.S. Employer Identification Number)
2900 University Blvd
Ames, IA 50010
(888) 275-3125
(Address of principal executive offices and zip code)
(888) 275-3125
(Registrant's telephone number, including area code)
___________________________________



Contact Personnel NameTest User
Entity Address Line 11000 Main St
Entity Address City or TownAmes
Entity Address State or ProvinceIA
Entity Address Postal Zip Code50010
City Area Code555
Local Phone Number333-4444
File Number333-12345
Tax ID Number12-3454444
Entity Interactive Data CurrentYes
Entity Incorporation State Country CodeIA
Annual ReportTRUE





Document and Entity Information
June 30, 20185/11/2018
Entity Registrant NameTest W K
Entity Central Index Key0000990763
Current Fiscal Year End Date9/30
Entity Filer CategoryLarge Accelerated Filer
Document Type10-K
Document Period End Date9/30/2020
Document Fiscal Year Focus2020
Document Fiscal Period FocusQ3
Emerging Growth Companyfalse
Transition Periodfalse
Small Businessfalse
Shell Companyfalse
Entity Voluntary FilersNo
Entity Well Known Seasoned IssuerNo
Entity Current Reporting StatusNo
Entity Public Float0
Amendment Flagfalse
Entity Common Stock, Shares Outstanding38,298,548 




This is a footnote

  
Three Months Ended
March 31,
(In millions, except for share and per-share amounts - Unaudited)March 31,
2012
March 31, 2011
Revenues:
Premiums, principally supplemental health insurance5,378 4,872 
Net investment income882 794 
Realized investment gains (losses):
Other-than-temporary impairment losses realized(203)(405)
Sales and redemptions78 (144)
Derivative and other gains (losses)80 (30)
Total realized investment gains (losses)(45)(579)
Other income25 30 
Total revenues6,240 5,117